trajectory analysis tool in discovery studio 2019 Search Results


90
Addinsoft inc xlstat software
Xlstat Software, supplied by Addinsoft inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trajectory+analysis+tool+in+discovery+studio+2019/xlstat+software/pmc07823927-112-9-16
Average 90 stars, based on 1 article reviews
xlstat software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd digimizer image analysis software v. 5.3.5
Digimizer Image Analysis Software V. 5.3.5, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trajectory+analysis+tool+in+discovery+studio+2019/digimizer+software/pmc09432465-69-5-13
Average 90 stars, based on 1 article reviews
digimizer image analysis software v. 5.3.5 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
RStudio open-source software rstudio version 1.2.5019
Open Source Software Rstudio Version 1.2.5019, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trajectory+analysis+tool+in+discovery+studio+2019/rstudio+version+1+3+1093/pmc08143140-171-6-8
Average 90 stars, based on 1 article reviews
open-source software rstudio version 1.2.5019 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
qsr international nvivo qualitative data analysis software v.12
Nvivo Qualitative Data Analysis Software V.12, supplied by qsr international, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trajectory+analysis+tool+in+discovery+studio+2019/nvivo+software/pm34821386-56-17-25
Average 90 stars, based on 1 article reviews
nvivo qualitative data analysis software v.12 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
treeage software pro 2019 software
Pro 2019 Software, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trajectory+analysis+tool+in+discovery+studio+2019/pro+2011+software/pm37373989-199-8-7
Average 90 stars, based on 1 article reviews
pro 2019 software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
treeage software treeage pro 2019
Treeage Pro 2019, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trajectory+analysis+tool+in+discovery+studio+2019/treeage+pro+2009/pmc07819651-89-7-10
Average 90 stars, based on 1 article reviews
treeage pro 2019 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

86
Partek imagej software nih
Imagej Software Nih, supplied by Partek, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trajectory+analysis+tool+in+discovery+studio+2019/imagej+nih+software/pmc08113880__mmc1-284-85-89
Average 86 stars, based on 1 article reviews
imagej software nih - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Synthego Inc crispr edits ice analysis tool
a, Schematics of key differences in Tfh cell maturation between humans (left) and mice (right). b, Gene expression signatures of all CD4 + T cell clusters from tonsillar T cell scRNA-seq. c, Volcano plot showing differential gene expression of GC-Tfh cells (left) vs. CXCL13 + GC-Tfh cells (right). d, Select subset-specific marker gene expression in Tfh, GC-Tfh, and CXCL13 + GC-Tfh cells. e, Schematic overview for assessment of CXCL13 production by non-, pre-, and GC-Tfh cells. f, Exemplary gating for non-Tfh (PD-1 - CXCR5 - ), pre-Tfh (PD-1 lo CXCR5 lo ), and GC-Tfh cells (PD-1 hi CXCR5 hi ). g, CXCL13 secretion by different sorted T cell subtypes cultured with or without B cells (n = 4). h, Schematic representation for <t>CRISPR/Cas9-based</t> editing of tonsil samples. i, CXCL13 ELISA of tonsillar cell culture supernatants for indicated transcription factor knockouts vs. scramble control (n = 14; ≤ 30 yo). Data were analyzed using two-way ANOVA with Šídák’s multiple comparison test ( g ) and one-way ANOVA with Dunnett’s multiple comparisons test ( i ). * P < 0.05, ** P < 0.01.
Crispr Edits Ice Analysis Tool, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trajectory+analysis+tool+in+discovery+studio+2019/inference+synthego/bio_rxiv__64898__2026__04__03__715992-314-12-17
Average 86 stars, based on 1 article reviews
crispr edits ice analysis tool - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

99
STATA Corporation stata software stata ic 14 2
a, Schematics of key differences in Tfh cell maturation between humans (left) and mice (right). b, Gene expression signatures of all CD4 + T cell clusters from tonsillar T cell scRNA-seq. c, Volcano plot showing differential gene expression of GC-Tfh cells (left) vs. CXCL13 + GC-Tfh cells (right). d, Select subset-specific marker gene expression in Tfh, GC-Tfh, and CXCL13 + GC-Tfh cells. e, Schematic overview for assessment of CXCL13 production by non-, pre-, and GC-Tfh cells. f, Exemplary gating for non-Tfh (PD-1 - CXCR5 - ), pre-Tfh (PD-1 lo CXCR5 lo ), and GC-Tfh cells (PD-1 hi CXCR5 hi ). g, CXCL13 secretion by different sorted T cell subtypes cultured with or without B cells (n = 4). h, Schematic representation for <t>CRISPR/Cas9-based</t> editing of tonsil samples. i, CXCL13 ELISA of tonsillar cell culture supernatants for indicated transcription factor knockouts vs. scramble control (n = 14; ≤ 30 yo). Data were analyzed using two-way ANOVA with Šídák’s multiple comparison test ( g ) and one-way ANOVA with Dunnett’s multiple comparisons test ( i ). * P < 0.05, ** P < 0.01.
Stata Software Stata Ic 14 2, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trajectory+analysis+tool+in+discovery+studio+2019/STATA+14%2E0/10__15666_slash_aeer_slash_2204_29592975-102-13-15
Average 99 stars, based on 1 article reviews
stata software stata ic 14 2 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
STATA Corporation stata version 16 1
a, Schematics of key differences in Tfh cell maturation between humans (left) and mice (right). b, Gene expression signatures of all CD4 + T cell clusters from tonsillar T cell scRNA-seq. c, Volcano plot showing differential gene expression of GC-Tfh cells (left) vs. CXCL13 + GC-Tfh cells (right). d, Select subset-specific marker gene expression in Tfh, GC-Tfh, and CXCL13 + GC-Tfh cells. e, Schematic overview for assessment of CXCL13 production by non-, pre-, and GC-Tfh cells. f, Exemplary gating for non-Tfh (PD-1 - CXCR5 - ), pre-Tfh (PD-1 lo CXCR5 lo ), and GC-Tfh cells (PD-1 hi CXCR5 hi ). g, CXCL13 secretion by different sorted T cell subtypes cultured with or without B cells (n = 4). h, Schematic representation for <t>CRISPR/Cas9-based</t> editing of tonsil samples. i, CXCL13 ELISA of tonsillar cell culture supernatants for indicated transcription factor knockouts vs. scramble control (n = 14; ≤ 30 yo). Data were analyzed using two-way ANOVA with Šídák’s multiple comparison test ( g ) and one-way ANOVA with Dunnett’s multiple comparisons test ( i ). * P < 0.05, ** P < 0.01.
Stata Version 16 1, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trajectory+analysis+tool+in+discovery+studio+2019/STATA+16%2E0/pmc12092943-52-5-5
Average 99 stars, based on 1 article reviews
stata version 16 1 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
STATA Corporation stata 16 1
a, Schematics of key differences in Tfh cell maturation between humans (left) and mice (right). b, Gene expression signatures of all CD4 + T cell clusters from tonsillar T cell scRNA-seq. c, Volcano plot showing differential gene expression of GC-Tfh cells (left) vs. CXCL13 + GC-Tfh cells (right). d, Select subset-specific marker gene expression in Tfh, GC-Tfh, and CXCL13 + GC-Tfh cells. e, Schematic overview for assessment of CXCL13 production by non-, pre-, and GC-Tfh cells. f, Exemplary gating for non-Tfh (PD-1 - CXCR5 - ), pre-Tfh (PD-1 lo CXCR5 lo ), and GC-Tfh cells (PD-1 hi CXCR5 hi ). g, CXCL13 secretion by different sorted T cell subtypes cultured with or without B cells (n = 4). h, Schematic representation for <t>CRISPR/Cas9-based</t> editing of tonsil samples. i, CXCL13 ELISA of tonsillar cell culture supernatants for indicated transcription factor knockouts vs. scramble control (n = 14; ≤ 30 yo). Data were analyzed using two-way ANOVA with Šídák’s multiple comparison test ( g ) and one-way ANOVA with Dunnett’s multiple comparisons test ( i ). * P < 0.05, ** P < 0.01.
Stata 16 1, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trajectory+analysis+tool+in+discovery+studio+2019/STATA+1%2E0/pm39809935-56-5-5
Average 99 stars, based on 1 article reviews
stata 16 1 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

90
OriginLab corp originpro-2019 (academic) software
a, Schematics of key differences in Tfh cell maturation between humans (left) and mice (right). b, Gene expression signatures of all CD4 + T cell clusters from tonsillar T cell scRNA-seq. c, Volcano plot showing differential gene expression of GC-Tfh cells (left) vs. CXCL13 + GC-Tfh cells (right). d, Select subset-specific marker gene expression in Tfh, GC-Tfh, and CXCL13 + GC-Tfh cells. e, Schematic overview for assessment of CXCL13 production by non-, pre-, and GC-Tfh cells. f, Exemplary gating for non-Tfh (PD-1 - CXCR5 - ), pre-Tfh (PD-1 lo CXCR5 lo ), and GC-Tfh cells (PD-1 hi CXCR5 hi ). g, CXCL13 secretion by different sorted T cell subtypes cultured with or without B cells (n = 4). h, Schematic representation for <t>CRISPR/Cas9-based</t> editing of tonsil samples. i, CXCL13 ELISA of tonsillar cell culture supernatants for indicated transcription factor knockouts vs. scramble control (n = 14; ≤ 30 yo). Data were analyzed using two-way ANOVA with Šídák’s multiple comparison test ( g ) and one-way ANOVA with Dunnett’s multiple comparisons test ( i ). * P < 0.05, ** P < 0.01.
Originpro 2019 (Academic) Software, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trajectory+analysis+tool+in+discovery+studio+2019/originpro+software/ppr0709846-62-11-14
Average 90 stars, based on 1 article reviews
originpro-2019 (academic) software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


a, Schematics of key differences in Tfh cell maturation between humans (left) and mice (right). b, Gene expression signatures of all CD4 + T cell clusters from tonsillar T cell scRNA-seq. c, Volcano plot showing differential gene expression of GC-Tfh cells (left) vs. CXCL13 + GC-Tfh cells (right). d, Select subset-specific marker gene expression in Tfh, GC-Tfh, and CXCL13 + GC-Tfh cells. e, Schematic overview for assessment of CXCL13 production by non-, pre-, and GC-Tfh cells. f, Exemplary gating for non-Tfh (PD-1 - CXCR5 - ), pre-Tfh (PD-1 lo CXCR5 lo ), and GC-Tfh cells (PD-1 hi CXCR5 hi ). g, CXCL13 secretion by different sorted T cell subtypes cultured with or without B cells (n = 4). h, Schematic representation for CRISPR/Cas9-based editing of tonsil samples. i, CXCL13 ELISA of tonsillar cell culture supernatants for indicated transcription factor knockouts vs. scramble control (n = 14; ≤ 30 yo). Data were analyzed using two-way ANOVA with Šídák’s multiple comparison test ( g ) and one-way ANOVA with Dunnett’s multiple comparisons test ( i ). * P < 0.05, ** P < 0.01.

Journal: bioRxiv

Article Title: Aging restricts maturation of CXCL13 + T follicular helper cells in human immunity

doi: 10.64898/2026.04.03.715992

Figure Lengend Snippet: a, Schematics of key differences in Tfh cell maturation between humans (left) and mice (right). b, Gene expression signatures of all CD4 + T cell clusters from tonsillar T cell scRNA-seq. c, Volcano plot showing differential gene expression of GC-Tfh cells (left) vs. CXCL13 + GC-Tfh cells (right). d, Select subset-specific marker gene expression in Tfh, GC-Tfh, and CXCL13 + GC-Tfh cells. e, Schematic overview for assessment of CXCL13 production by non-, pre-, and GC-Tfh cells. f, Exemplary gating for non-Tfh (PD-1 - CXCR5 - ), pre-Tfh (PD-1 lo CXCR5 lo ), and GC-Tfh cells (PD-1 hi CXCR5 hi ). g, CXCL13 secretion by different sorted T cell subtypes cultured with or without B cells (n = 4). h, Schematic representation for CRISPR/Cas9-based editing of tonsil samples. i, CXCL13 ELISA of tonsillar cell culture supernatants for indicated transcription factor knockouts vs. scramble control (n = 14; ≤ 30 yo). Data were analyzed using two-way ANOVA with Šídák’s multiple comparison test ( g ) and one-way ANOVA with Dunnett’s multiple comparisons test ( i ). * P < 0.05, ** P < 0.01.

Article Snippet: Editing efficiencies ( Table S3 ) were calculated using the Inference of CRISPR Edits (ICE) analysis tool (Synthego Performance Analysis 2019, v3.0) to ensure target gene knockout.

Techniques: Gene Expression, Marker, Cell Culture, CRISPR, Enzyme-linked Immunosorbent Assay, Control, Comparison

a, Number of differentially expressed genes (DEGs, >50yo vs. <30yo) over pseudotime during Tfh cell development from naïve CD4 + T cells (left) to CXCL13 + GC-Tfh cells (right). False discovery rate (FDR) is set to < 0.05. b, Volcano plot showing differential gene expression of Tfh cells from older (left) vs. younger donors (right). c, Schematic representation for CRISPR/Cas9-based editing of naïve CD4 + T cells followed by T cell polarization and flow cytometric analysis. d, Expression of CXCR5, FOXP3, and PD-1 in naïve CD4 + T cells cultured under Tfh-polarizing conditions (dark grey) or non-polarizing conditions (light grey). e, Log2 fold change relative to matched scramble controls for Th1 (left) and Th17 (right) cell frequency in TF-knockouts under Th1- or Th17-polarizing conditions. f, Log2 fold change relative to matched scramble controls for Tfh cell frequency in TF-knockouts under Tfh-polarizing conditions (gated on CD4 + CD19 - FOXP3 - CXCR5 + PD-1 + cells). Data were analyzed using a mixed effects model and Dunnett’s multiple comparisons test ( f ), one sample t test ( e ). Error bars SEM ( e-f ). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: bioRxiv

Article Title: Aging restricts maturation of CXCL13 + T follicular helper cells in human immunity

doi: 10.64898/2026.04.03.715992

Figure Lengend Snippet: a, Number of differentially expressed genes (DEGs, >50yo vs. <30yo) over pseudotime during Tfh cell development from naïve CD4 + T cells (left) to CXCL13 + GC-Tfh cells (right). False discovery rate (FDR) is set to < 0.05. b, Volcano plot showing differential gene expression of Tfh cells from older (left) vs. younger donors (right). c, Schematic representation for CRISPR/Cas9-based editing of naïve CD4 + T cells followed by T cell polarization and flow cytometric analysis. d, Expression of CXCR5, FOXP3, and PD-1 in naïve CD4 + T cells cultured under Tfh-polarizing conditions (dark grey) or non-polarizing conditions (light grey). e, Log2 fold change relative to matched scramble controls for Th1 (left) and Th17 (right) cell frequency in TF-knockouts under Th1- or Th17-polarizing conditions. f, Log2 fold change relative to matched scramble controls for Tfh cell frequency in TF-knockouts under Tfh-polarizing conditions (gated on CD4 + CD19 - FOXP3 - CXCR5 + PD-1 + cells). Data were analyzed using a mixed effects model and Dunnett’s multiple comparisons test ( f ), one sample t test ( e ). Error bars SEM ( e-f ). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: Editing efficiencies ( Table S3 ) were calculated using the Inference of CRISPR Edits (ICE) analysis tool (Synthego Performance Analysis 2019, v3.0) to ensure target gene knockout.

Techniques: Gene Expression, CRISPR, Expressing, Cell Culture